AzTrials
AzTrials

Vaginal Cuff ComplicationsNCT07174921

Post-hysterectomy Vaginal Cuff Prolapse Repair

A study testing Laparoscopic Lateral Suspension and Laparoscopic Sacrocolpopexy in people with Vaginal Cuff Complications, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a randomized controlled trial comparing two minimally invasive surgeries-laparoscopic lateral suspension and laparoscopic sacrocolporopexy-for women who develop vaginal cuff prolapse after hysterectomy. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Vaginal Cuff Complications
What is being tested?
Laparoscopic Lateral Suspension and Laparoscopic Sacrocolpopexy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Sep 2025to 15 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women aged ≥18 years.
  • History of hysterectomy (any approach: abdominal, vaginal, or laparoscopic).
  • Symptomatic vaginal cuff prolapse (POP-Q stage ≥ II).
  • Able to provide written informed consent.
  • Willing and able to comply with study procedures and follow-up visits.

Who cannot join

  • Prior sacrocolpopexy or lateral suspension surgery.
  • Active pelvic infection or untreated malignancy.
  • Severe cardiopulmonary or systemic disease that contraindicates laparoscopic surgery.
  • Known allergy to mesh materials used in the procedures.
  • Inability to complete patient-reported questionnaires due to cognitive or language barriers.
  • Concurrent pelvic organ prolapse requiring additional surgical repair beyond vaginal cuff suspension.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ozan Karadeniz, MD contact

+905333663003

dr.ozankrdnz@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Basaksehir Cam and Sakura City Hospital

    Istanbul, Istanbul, 34494

    Ozan Karadeniz, 05333663003, dr.ozankrdnz@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Laparoscopic Lateral Suspension Versus Laparoscopic Sacrocolpopexy for Post-Hysterectomy Vaginal Cuff Prolapse: A Randomized Controlled Trial

This study is a randomized controlled trial comparing two minimally invasive surgeries-laparoscopic lateral suspension and laparoscopic sacrocolporopexy-for women who develop vaginal cuff prolapse after hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses support after the uterus is removed, which can cause discomfort, bulging, or urinary and bowel problems.

The goal of this study is to determine which surgical approach is safer, more effective, and improves quality of life for patients. Women enrolled in the trial will be randomly assigned to one of the two surgeries, and outcomes such as prolapse recurrence, complications, recovery time, and patient satisfaction will be carefully monitored.

By comparing these two techniques, this study aims to provide clear guidance for surgeons and patients to make informed decisions about the best surgical treatment for post-hysterectomy vaginal cuff prolapse.

Read the detailed description

This study is a randomized controlled trial (RCT) designed to compare the outcomes of two minimally invasive surgical techniques-laparoscopic lateral suspension and laparoscopic sacrocolpopexy-for the treatment of vaginal cuff prolapse following hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses its normal support after the uterus has been removed, leading to symptoms such as a sensation of vaginal bulging, pelvic pressure, urinary or bowel dysfunction, and discomfort during daily activities or sexual intercourse.

Eligible participants are women who have previously undergone hysterectomy and are experiencing symptomatic vaginal cuff prolapse. Participants will be randomly assigned to undergo either laparoscopic lateral suspension or laparoscopic sacrocolpopexy. Both procedures are performed using minimally invasive laparoscopic techniques, which typically result in smaller incisions, less pain, and faster recovery compared to traditional open surgery.

The study will assess multiple clinical and patient-reported outcomes, including:

Anatomical success: Prevention of prolapse recurrence at follow-up visits.

Functional outcomes: Improvement in urinary, bowel, and sexual function.

Complications: Intraoperative and postoperative adverse events.

Recovery metrics: Length of hospital stay, return to daily activities, and postoperative pain.

Patient satisfaction: Quality of life and overall satisfaction with the procedure.

By conducting this study, researchers aim to provide evidence-based guidance on which surgical approach offers better long-term outcomes, fewer complications, and higher patient satisfaction. The results of this trial may help clinicians make informed decisions and improve the care of women with post-hysterectomy vaginal cuff prolapse.

Being tested
Laparoscopic Lateral Suspension, Laparoscopic Sacrocolpopexy
Keywords
prolapse, vaginal cuff, lateral suspension, sacrocolpopexy
Medical subject headings
Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic Lateral SuspensionProcedure or surgery

    Also called Lateral Suspension (Apical Suspension)

    Participants in this arm will undergo laparoscopic lateral suspension for post-hysterectomy vaginal cuff prolapse. The procedure involves attaching a synthetic mesh from the vaginal cuff to the lateral abdominal wall to provide support and restore normal vaginal anatomy. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.

  • Laparoscopic SacrocolpopexyProcedure or surgery

    Participants in this arm will undergo laparoscopic sacrohysteropexy for post-hysterectomy vaginal cuff prolapse. The procedure involves suspending the vaginal cuff to the sacral promontory using a synthetic mesh, restoring vaginal support. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.

Study groups in NCT07174921
Study groupRoleWhat they receive
Laparoscopic SacrocolpopexyActive comparatorNot described
Receives: Procedure: Laparoscopic Sacrocolpopexy
Laparoscopic Lateral SuspensionExperimentalNot described
Receives: Procedure: Laparoscopic Lateral Suspension

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anatomical Success (Point C of POP-Q System)

    Vaginal cuff support measured objectively using POP-Q system, focusing on point C (position of the vaginal apex relative to the hymen). Success is defined as point C remaining above the hymen at follow-up by a blinded examiner.

    Measured: 12 months post-surgery

Secondary outcomes (6)
  1. Operative Time

    Total duration of the surgery measured in minutes from incision to closure.

    Measured: During surgery

  2. Postoperative Hospital Stay

    Length of hospital stay in days from surgery to discharge.

    Measured: From the day of surgery through hospital discharge (an expected average of 2 days)

  3. Postoperative Complications

    Includes mesh exposure, infection, bleeding, urinary or bowel injury, and reoperation.

    Measured: Up to 12 months post-surgery

  4. Pelvic Floor Distress Inventory (PFDI-20)

    Patient-reported measure of prolapse, urinary, and bowel symptoms.

    The PFDI-20 consists of 3 subscales:

    Pelvic Organ Prolapse Distress Inventory (POPDI-6)

    Colorectal-Anal Distress Inventory (CRADI-8)

    Urinary Distress Inventory (UDI-6) Each subscale is scored 0-100, and the total score is the sum of the three subscales (0-300).

    0 = no pelvic floor-related distress at all.

    300 = the maximum possible distress, meaning the respondent endorsed the highest level of bother on all 20 items.

    Measured: Preoperative and 12 months post-surgery

  5. Pelvic Floor Impact Questionnaire (PFIQ-7)

    Patient-reported measure of the impact of pelvic floor disorders on daily activities, relationships, and quality of life.

    The PFIQ-7 includes 3 subscales:

    Urinary Impact Questionnaire (UIQ-7)

    Colorectal-Anal Impact Questionnaire (CRAIQ-7)

    Pelvic Organ Prolapse Impact Questionnaire (POPIQ-7)

    Each subscale contains items scored 0-3 ("not at all" to "quite a bit"), then converted to a 0-100 scale.

    The three subscales are summed for a total score ranging from 0 to 300.

    0 = no impact on quality of life.

    300 = maximum impact across all domains (urinary, colorectal-anal, and prolapse).

    Higher scores indicate worse quality-of-life impairment due to pelvic floor disorders.

    Measured: Preoperative and 12 months post-surgery

  6. Patient Global Impression (PGI) Scale

    Patient-reported scale evaluating overall improvement or satisfaction with surgery, typically rated from 1 ("very much improved") to 7 ("very much worse").

    Measured: Preoperative and 12 months post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2025
  2. Study start30 Sep 2025 (estimated)
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion15 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07174921
Sponsor's protocol ID
CSC Hospital
Status last verified
Sep 2025
First submitted
7 Sep 2025
Last updated
16 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Laparoscopic Lateral Suspension and Laparoscopic Sacrocolpopexy in people with Vaginal Cuff Complications, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ozan Karadeniz, MD (+905333663003, dr.ozankrdnz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anatomical Success (Point C of POP-Q System) (time frame: 12 months post-surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in